FGF9 and endometrial cancer: To investigate the suppression effects of Sox7 on Wnt/β-catenin activity of endometrial cancer, we particularly examined the expression levels of CyclinD1 and FGF9 in β-catenin highly expressing endometrial cancer samples which had either with or without expression of Sox7.